Literature DB >> 27001854

Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity.

Jennifer R Hamilton1, David Sachs2, Jean K Lim1, Ryan A Langlois3, Peter Palese4, Nicholas S Heaton5.   

Abstract

A brief window of antigen-nonspecific protection has been observed after influenza A virus (IAV) infection. Although this temporary immunity has been assumed to be the result of residual nonspecific inflammation, this period of induced immunity has not been fully studied. Because IAV has long been characterized as a cytopathic virus (based on its ability to rapidly lyse most cell types in culture), it has been a forgone conclusion that directly infected cells could not be contributing to this effect. Using a Cre recombinase-expressing IAV, we have previously shown that club cells can survive direct viral infection. We show here not only that these cells can eliminate all traces of the virus and survive but also that they acquire a heightened antiviral response phenotype after surviving. Moreover, we experimentally demonstrate temporary nonspecific viral immunity after IAV infection and show that surviving cells are required for this phenotype. This work characterizes a virally induced modulation of the innate immune response that may represent a new mechanism to prevent viral diseases.

Entities:  

Keywords:  RNA sequencing; alternative cell fate; antiviral immunity; influenza virus

Mesh:

Substances:

Year:  2016        PMID: 27001854      PMCID: PMC4833272          DOI: 10.1073/pnas.1522376113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Epithelial repair mechanisms in the lung.

Authors:  Lynn M Crosby; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-02       Impact factor: 5.464

2.  Impact of the 2009 influenza A(H1N1) pandemic wave on the pattern of hibernal respiratory virus epidemics, France, 2009.

Authors:  J S Casalegno; M Ottmann; M Bouscambert-Duchamp; M Valette; F Morfin; B Lina
Journal:  Euro Surveill       Date:  2010-02-11

3.  A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration.

Authors:  Thorsten Buch; Frank L Heppner; Christine Tertilt; Tobias J A J Heinen; Marcel Kremer; F Thomas Wunderlich; Steffen Jung; Ari Waisman
Journal:  Nat Methods       Date:  2005-06       Impact factor: 28.547

Review 4.  Tissue-resident memory T cells.

Authors:  Jason M Schenkel; David Masopust
Journal:  Immunity       Date:  2014-12-06       Impact factor: 31.745

5.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain.

Authors:  Linda Madisen; Theresa A Zwingman; Susan M Sunkin; Seung Wook Oh; Hatim A Zariwala; Hong Gu; Lydia L Ng; Richard D Palmiter; Michael J Hawrylycz; Allan R Jones; Ed S Lein; Hongkui Zeng
Journal:  Nat Neurosci       Date:  2009-12-20       Impact factor: 24.884

Review 6.  Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function.

Authors:  Brigid L M Hogan; Christina E Barkauskas; Harold A Chapman; Jonathan A Epstein; Rajan Jain; Connie C W Hsia; Laura Niklason; Elizabeth Calle; Andrew Le; Scott H Randell; Jason Rock; Melinda Snitow; Matthew Krummel; Barry R Stripp; Thiennu Vu; Eric S White; Jeffrey A Whitsett; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2014-08-07       Impact factor: 24.633

7.  Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine.

Authors:  Benjamin J Cowling; Vicky J Fang; Hiroshi Nishiura; Kwok-Hung Chan; Sophia Ng; Dennis K M Ip; Susan S Chiu; Gabriel M Leung; J S Malik Peiris
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

8.  Binary recombinase systems for high-resolution conditional mutagenesis.

Authors:  Mario Hermann; Patrick Stillhard; Hendrik Wildner; Davide Seruggia; Viktor Kapp; Héctor Sánchez-Iranzo; Nadia Mercader; Lluís Montoliu; Hanns Ulrich Zeilhofer; Pawel Pelczar
Journal:  Nucleic Acids Res       Date:  2014-01-09       Impact factor: 16.971

9.  Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model.

Authors:  Karen L Laurie; Teagan A Guarnaccia; Louise A Carolan; Ada W C Yan; Malet Aban; Stephen Petrie; Pengxing Cao; Jane M Heffernan; Jodie McVernon; Jennifer Mosse; Anne Kelso; James M McCaw; Ian G Barr
Journal:  J Infect Dis       Date:  2015-05-05       Impact factor: 5.226

10.  The impact of pandemic influenza A (H1N1) 2009 on the circulation of respiratory viruses 2009-2011.

Authors:  Gannon C Mak; Ann H Wong; Winnie Y Y Ho; Wilina Lim
Journal:  Influenza Other Respir Viruses       Date:  2012-01-02       Impact factor: 4.380

View more
  23 in total

1.  A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor.

Authors:  Brook E Heaton; Edward M Kennedy; Rebekah E Dumm; Alfred T Harding; Matthew T Sacco; David Sachs; Nicholas S Heaton
Journal:  Cell Rep       Date:  2017-08-15       Impact factor: 9.423

2.  Mice with diverse microbial exposure histories as a model for preclinical vaccine testing.

Authors:  Jessica K Fiege; Katharine E Block; Mark J Pierson; Hezkiel Nanda; Frances K Shepherd; Clayton K Mickelson; J Michael Stolley; William E Matchett; Sathi Wijeyesinghe; David K Meyerholz; Vaiva Vezys; Steven S Shen; Sara E Hamilton; David Masopust; Ryan A Langlois
Journal:  Cell Host Microbe       Date:  2021-11-02       Impact factor: 21.023

3.  Evidence for influenza and RSV interaction from 10 years of enhanced surveillance in Nha Trang, Vietnam, a modelling study.

Authors:  Naomi R Waterlow; Michiko Toizumi; Edwin van Leeuwen; Hien-Anh Thi Nguyen; Lay Myint-Yoshida; Rosalind M Eggo; Stefan Flasche
Journal:  PLoS Comput Biol       Date:  2022-06-24       Impact factor: 4.779

4.  Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo.

Authors:  Louisa E Sjaastad; Elizabeth J Fay; Jessica K Fiege; Marissa G Macchietto; Ian A Stone; Matthew W Markman; Steven Shen; Ryan A Langlois
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

5.  Distinct Chronic Post-Viral Lung Diseases upon Infection with Influenza or Parainfluenza Viruses Differentially Impact Superinfection Outcome.

Authors:  Geyon L Garcia; Alex Valenzuela; Tomaz Manzoni; Andrew E Vaughan; Carolina B López
Journal:  Am J Pathol       Date:  2019-12-19       Impact factor: 4.307

6.  Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection.

Authors:  Mitchell A Luangrath; Megan E Schmidt; Stacey M Hartwig; Steven M Varga
Journal:  Immunohorizons       Date:  2021-02-03

7.  Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine.

Authors:  Young J Lee; Jeong Y Lee; Yo H Jang; Sang-Uk Seo; Jun Chang; Baik L Seong
Journal:  Front Microbiol       Date:  2018-01-31       Impact factor: 5.640

8.  Seasonality in risk of pandemic influenza emergence.

Authors:  Spencer J Fox; Joel C Miller; Lauren Ancel Meyers
Journal:  PLoS Comput Biol       Date:  2017-10-19       Impact factor: 4.475

Review 9.  Revisiting the concept of a cytopathic viral infection.

Authors:  Nicholas S Heaton
Journal:  PLoS Pathog       Date:  2017-07-20       Impact factor: 6.823

10.  A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies.

Authors:  Randy A Albrecht; Florian Krammer; Raffael Nachbagauer; Wen-Chun Liu; Angela Choi; Teddy John Wohlbold; Talia Atlas; Madhusudan Rajendran; Alicia Solórzano; Francesco Berlanda-Scorza; Adolfo García-Sastre; Peter Palese
Journal:  NPJ Vaccines       Date:  2017-09-14       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.